Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (271-280 of 426) with videos related to

Pageof 43
Sort By:
Lupus|December 1, 1994
Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosyM Hojnik, B Gilburd, L Ziporen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigensTao Dao, Marta Gomez-Nunez, Christophe Antczak, et al.
Leukemia|September 20, 2000
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapyM A Weiss, M Glenn, P Maslak, et al.
Molecular and Cellular Biology|September 1, 2010
Inhibition of human peptide deformylase disrupts mitochondrial functionSindy Escobar-Alvarez, Jeffrey Gardner, Aneesh Sheth, et al.
Immunological Reviews|July 16, 2023
Challenges and solutions for therapeutic TCR-based agentsManish Malviya, Zita E H Aretz, Zaki Molvi, et al.
Journal of Molecular Biology|December 22, 2015
Structure of a TCR-Mimic Antibody with Target Predicts PharmacogeneticsNiloufar Ataie, Jingyi Xiang, Neal Cheng, et al.
The Journal of Experimental Medicine|June 1, 1996
The multidrug resistance phenotype confers immunological resistanceJ H Weisburg, M Curcio, P C Caron, et al.
Elife|December 1, 2018
Rejection of immunogenic tumor clones is limited by clonal fractionRon S Gejman, Aaron Y Chang, Heather F Jones, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2011
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylaseChristophe Antczak, David Shum, Bhramdeo Bassit, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2021
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejectionLeila Peraro, Christopher M Bourne, Megan M Dacek, et al.
Pageof 43

Showing results (271-280 of 426) with videos related to

Sort By:
Pageof 43
Lupus|December 1, 1994
Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosyM Hojnik, B Gilburd, L Ziporen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigensTao Dao, Marta Gomez-Nunez, Christophe Antczak, et al.
Leukemia|September 20, 2000
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapyM A Weiss, M Glenn, P Maslak, et al.
Molecular and Cellular Biology|September 1, 2010
Inhibition of human peptide deformylase disrupts mitochondrial functionSindy Escobar-Alvarez, Jeffrey Gardner, Aneesh Sheth, et al.
Immunological Reviews|July 16, 2023
Challenges and solutions for therapeutic TCR-based agentsManish Malviya, Zita E H Aretz, Zaki Molvi, et al.
Journal of Molecular Biology|December 22, 2015
Structure of a TCR-Mimic Antibody with Target Predicts PharmacogeneticsNiloufar Ataie, Jingyi Xiang, Neal Cheng, et al.
The Journal of Experimental Medicine|June 1, 1996
The multidrug resistance phenotype confers immunological resistanceJ H Weisburg, M Curcio, P C Caron, et al.
Elife|December 1, 2018
Rejection of immunogenic tumor clones is limited by clonal fractionRon S Gejman, Aaron Y Chang, Heather F Jones, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2011
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylaseChristophe Antczak, David Shum, Bhramdeo Bassit, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2021
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejectionLeila Peraro, Christopher M Bourne, Megan M Dacek, et al.
Pageof 43